Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defects of mitochondrial DNA.

M Zeviani1, C Antozzi

  • 1Carlo Besta National Institute of Neurology, Milano, Italy.

Brain Pathology (Zurich, Switzerland)
|April 1, 1992
PubMed
Summary

Mitochondrial DNA (mtDNA) lesions cause various neurological syndromes. Molecular detection of these defects aids in diagnosing mitochondrial disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of the Myasthenia Gravis TeleScore (MGTS).

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Strategies for fighting mitochondrial diseases.

Journal of internal medicine·2020
Same author

Adult-onset Rasmussen encephalitis treated with mitoxantrone.

European journal of neurology·2018
Same author

SURF1 knockout cloned pigs: Early onset of a severe lethal phenotype.

Biochimica et biophysica acta. Molecular basis of disease·2018
Same author

AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome.

Gene therapy·2017
Same author

Revisiting mitochondrial ocular myopathies: a study from the Italian Network.

Journal of neurology·2017

Area of Science:

  • Genetics and Molecular Biology
  • Neurology
  • Mitochondrial Medicine

Background:

  • Human mitochondrial DNA (mtDNA) encodes crucial respiratory chain components and is linked to several distinct syndromes.
  • MtDNA-related disorders are broadly classified into mitochondrial encephalomyopathies with ragged-red fibres (RRF) and "pure" encephalopathies without RRF.
  • Examples include MERRF, MELAS, KSS, CPEO, maternally inherited myopathy and cardiomyopathy, LHON, and ataxia-retinitis pigmentosa-dementia complex.

Purpose of the Study:

  • To categorize mtDNA-related syndromes based on clinical presentation and underlying molecular pathology.
  • To correlate specific types of mtDNA lesions with distinct clinical phenotypes and inheritance patterns.
  • To highlight the diagnostic utility of molecular detection for mitochondrial disorders.

Main Methods:

  • Classification of syndromes based on morphological hallmarks (RRF) and clinical features.
  • Identification of three primary molecular lesion types: point mutations in mtDNA-genes, point mutations in mtDNA-tRNA genes, and large-scale mtDNA rearrangements.
  • Analysis of inheritance patterns (maternal, sporadic, Mendelian) associated with different mutation types.

Main Results:

  • "Mit-" mutations are generally linked to non-RRF encephalopathies, while "syn-" and "rho-" mutations are associated with RRF-positive mitochondrial encephalomyopathies.
  • Point mutations (mit- and syn-) typically exhibit maternal inheritance.
  • Large-scale mtDNA rearrangements are often sporadic or follow Mendelian inheritance.

Conclusions:

  • Specific molecular defects in mtDNA correlate with distinct clinical syndromes and inheritance patterns.
  • Non-invasive molecular testing for mtDNA defects is a valuable and cost-effective tool for diagnosing mitochondrial disorders.
  • This diagnostic approach is crucial in the differential diagnosis of an expanding range of clinical neurological conditions.

Related Experiment Videos